RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...

A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing strategy that could potentially lead to a one-time treatment for multiple ...

Blood sample drawn from sickle cell disease patient Tristen Tate, Friday, March 8, 2024, at Cook Children's Hematology and Oncology in Fort Worth. Shafkat Anowar / Staff Photographer A Dallas ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Cancer: it’s a diagnosis that most of us have learned to fear. On the one hand decades ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA — best known for being used in Covid-19 vaccines — in the hopes of ...

IQ Consortium experts explain how advanced chromatographic and analytical strategies are improving the bioanalysis, ...

The loss of American chestnut trees, Castanea denatata, ranks as one of the most devastating botanical disasters in U.S. history. Before the introduction of chestnut blight in 1904, there were over 4 ...